AI

By Dave Muoio 03:30 pm November 25, 2019
Nines, a tele-radiology and artificial intelligence startup, unveiled its software platform alongside news of a $16.5 million Series A raise. The funding was led by Accel and 8VC, with individual participants also taking part. WHAT THEY DO The two-year-old startup’s efforts are broken into two camps. On the one hand is a tele-radiology service that’s staffed by live specialists, and according to...
By Laura Lovett 03:18 pm November 19, 2019
Ada Health is expanding its services in East Africa with a new Swahili language version of its artificial intelligence assessment app.  The tool is pitched as a way for clinicians and patients to get more information about potential symptom causes as well as localized action steps about what to do next.  “The Swahili version of the Ada app can be accessed via smartphone, and offers support to...
By Dave Muoio 03:50 pm November 7, 2019
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding. Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
By Dave Muoio 11:20 am November 6, 2019
Boston-based PathAI, maker of artificial intelligence tools for pathology, has capped off its Series B funding round with a $15 million strategic investment from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. This raise brings the startup’s full round to $75 million, and its total funding to just over $90 million. WHAT THEY DO PathAI’s platform employs convolutional neural...
By Tammy Lovell 05:18 am October 18, 2019
Health tech firm Healx, which specialises in treatments for rare diseases, has raised $56m (£43.4m) in a Series B financing round led by European VC firm Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous investors, including Balderton Capital, Amadeus Capital Partners, and Jonathan Milner also participated in the round. The funding follows a $10m Series A round in...

Credit: Ieso Digital Health

By Leontina Postelnicu 05:57 am October 16, 2019
The digital therapeutics field has attracted the interest of major players in the healthcare industry lately, from big pharma to the NHS. But there is debate among stakeholders around issues including reimbursement, regulation and business models that work. The space, however, continues to grow, and Cambridge-headquartered Ieso Digital Health unveiled earlier this year plans to build an...
By MobiHealthNews 02:20 pm October 15, 2019
Digital chronic disease management company Livongo Health announced a partnership today with VSP Vision Care that will blend each service for the companies’ mutual clients. More specifically, Livongo members with diabetes who are also under “most” VSP plans will be offered retinal screenings from VSP network doctors, and receive messages through the digital program prompting them to seek eye care...
By Tammy Lovell 09:16 am October 15, 2019
French health tech startup Primaa has raised €2m to accelerate the development and the international marketing of its automated diagnostic products. The Paris-based firm, founded in 2018, develops software tools which use artificial intelligence (AI) and deep learning to assist anatomical pathologists with cancer and other diagnoses. It is currently in the process of finalising its first tool...
By Dave Muoio 03:20 pm October 3, 2019
Diligent Robotics, maker of an autonomous robot assistant for hospitals, has raised $3 million in seed funding. The raise was headed by True Ventures and Ubiquity Ventures, as well as Next Coast Ventures, Capital Factory, Pathbreaker Ventures, Boom Capital, Grit Ventures and other unnamed angel investors. This adds to another $2.1 million round announced back in the beginning of 2018, as well as...
By Laura Lovett 01:18 pm October 1, 2019
Novartis is teaming up with Microsoft on a new artificial intelligence initiative focused on drug discovery and development. The new efforts will primarily be focused in Novartis’ newly announced AI innovation lab.  As part of the deal Novartis will be employing Microsoft’s AI tools to help its scientist with computational hurdles in life sciences including generative chemistry, image...